{"id":38574,"date":"2026-01-14T09:19:05","date_gmt":"2026-01-14T08:19:05","guid":{"rendered":"https:\/\/immunostep.com\/?p=38574"},"modified":"2025-12-22T14:45:35","modified_gmt":"2025-12-22T13:45:35","slug":"advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays","status":"publish","type":"post","link":"https:\/\/immunostep.com\/es\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/","title":{"rendered":"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays"},"content":{"rendered":"<p data-start=\"261\" data-end=\"764\"><strong data-start=\"261\" data-end=\"288\">Cytokine quantification<\/strong> is a cornerstone of immunology, oncology, and advanced cell therapies. In complex clinical scenarios such as <strong data-start=\"398\" data-end=\"433\">cytokine release syndrome (CRS)<\/strong> associated with<a href=\"https:\/\/immunostep.com\/immunology\/car-t\/?v=12470fe406d4\"> CAR-T therapies<\/a> or bispecific antibodies, the ability to measure multiple analytes with <strong data-start=\"538\" data-end=\"584\">high sensitivity using microvolume samples<\/strong> has become a critical requirement. In this context, <strong data-start=\"637\" data-end=\"675\">advanced multiplexing technologies<\/strong> have rapidly evolved, with platforms such as <strong data-start=\"721\" data-end=\"750\">Luminex, Olink, and Simoa<\/strong> standing out.<\/p>\n<h2 data-start=\"771\" data-end=\"815\">The Need for Cytokine Multiplexing in Microvolumes<\/h2>\n<p data-start=\"817\" data-end=\"1258\">Modern assays increasingly demand more information from <strong data-start=\"873\" data-end=\"899\">limited sample volumes<\/strong>, particularly in longitudinal studies, pediatric settings, or preclinical research. Multiplexing enables the simultaneous analysis of <strong data-start=\"1034\" data-end=\"1057\">dozens of cytokines<\/strong>, reducing sample consumption, assay time, and experimental variability. However, not all technologies provide the same balance between <strong data-start=\"1193\" data-end=\"1257\">sensitivity, dynamic range, and robustness to matrix effects<\/strong>.<\/p>\n<h2>Technical Comparison: Luminex, Olink, and Simoa<\/h2>\n<p data-start=\"1317\" data-end=\"1729\"><strong data-start=\"1317\" data-end=\"1328\">Luminex<\/strong> technology, based on fluorescently coded microspheres, has long been a standard in multiplex cytokine assays. It allows simultaneous detection of multiple cytokines in a single well, offering a solid balance between <strong data-start=\"1545\" data-end=\"1582\">cost, flexibility, and throughput<\/strong>. Nevertheless, its <strong data-start=\"1602\" data-end=\"1624\">limit of detection<\/strong> may be insufficient for low-abundance cytokines that are clinically relevant in the early stages of CRS.<\/p>\n<p data-start=\"1731\" data-end=\"2134\">In contrast, <strong data-start=\"1744\" data-end=\"1753\">Olink<\/strong> employs a <strong data-start=\"1764\" data-end=\"1799\">Proximity Extension Assay (PEA)<\/strong> approach, where dual antibody recognition is coupled with PCR-based signal amplification. This technology excels in <strong data-start=\"1916\" data-end=\"1936\">high sensitivity<\/strong>, strong performance in <strong data-start=\"1960\" data-end=\"1983\">microvolume samples<\/strong>, and reduced susceptibility to matrix interference. However, its closed format and reliance on predefined panels may limit experimental customization.<\/p>\n<p data-start=\"2136\" data-end=\"2514\">At the high end of sensitivity, <strong data-start=\"2168\" data-end=\"2201\">Simoa (Single Molecule Array)<\/strong> enables cytokine detection at <strong data-start=\"2232\" data-end=\"2261\">femtomolar concentrations<\/strong> by reading individual molecules. This ultra-sensitive capability is particularly relevant for <strong data-start=\"2356\" data-end=\"2380\">early CRS biomarkers<\/strong>, although it is often accompanied by <strong data-start=\"2418\" data-end=\"2485\">greater instrumental complexity and lower multiplexing capacity<\/strong> compared to other platforms.<\/p>\n<h2>Limit of Detection: A Critical Parameter in CRS<\/h2>\n<p data-start=\"2573\" data-end=\"3003\">In the context of <strong data-start=\"2591\" data-end=\"2620\">cytokine release syndrome<\/strong>, early detection of mediators such as <strong data-start=\"2659\" data-end=\"2692\">IL-6, IL-1\u03b2, IFN-\u03b3, and TNF-\u03b1<\/strong> can be decisive for clinical decision-making. Assays must achieve <strong data-start=\"2759\" data-end=\"2791\">very low limits of detection<\/strong> while maintaining accuracy and reproducibility. This is where technologies like <strong data-start=\"2872\" data-end=\"2891\">Olink and Simoa<\/strong> offer clear advantages over more conventional multiplex platforms, particularly during the early phases of CRS.<\/p>\n<h2>Validation of Hemolyzed or Lipemic Samples<\/h2>\n<p data-start=\"3057\" data-end=\"3386\">A common challenge in real-world clinical studies is sample quality. <strong data-start=\"3126\" data-end=\"3151\">Hemolysis and lipemia<\/strong> can introduce significant interferences in cytokine quantification, affecting both signal intensity and assay specificity. For this reason, <strong data-start=\"3292\" data-end=\"3332\">validation using compromised samples<\/strong> is a critical step in any robust analytical workflow.<\/p>\n<p data-start=\"3388\" data-end=\"3765\">Advanced multiplex platforms should be evaluated not only under ideal conditions but also in the presence of <strong data-start=\"3497\" data-end=\"3528\">complex biological matrices<\/strong>, ensuring that results remain interpretable and comparable. Strategies such as internal controls, recovery studies, and interference testing are essential to guarantee <strong data-start=\"3697\" data-end=\"3717\">data reliability<\/strong>, especially in translational research setting.<\/p>\n<h2>Conclusion<\/h2>\n<p data-start=\"3787\" data-end=\"4291\"><strong data-start=\"3787\" data-end=\"3856\">Advanced multiplexing for cytokine quantification in microvolumes<\/strong> has become an indispensable tool in immunology and cell therapy research. The choice between <strong data-start=\"3950\" data-end=\"3979\">Luminex, Olink, and Simoa<\/strong> should be guided by the <strong data-start=\"4004\" data-end=\"4035\">required limit of detection<\/strong>, number of analytes, sample availability, and clinical context of the study. In demanding applications such as <strong data-start=\"4147\" data-end=\"4161\">CRS assays<\/strong>, sensitivity, robustness to sample quality issues, and reproducibility are key factors for generating clinically meaningful data<a href=\"https:\/\/www.linkedin.com\/company\/36113352\/admin\/page-posts\/published\/\">.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cytokine quantification is a cornerstone of immunology, oncology, and advanced cell therapies. In complex clinical scenarios such as cytokine release syndrome (CRS) associated with CAR-T therapies or bispecific antibodies, the ability to measure multiple analytes with high sensitivity using microvolume samples has become a critical requirement. In this context, advanced multiplexing technologies have rapidly evolved, [&hellip;]<\/p>\n","protected":false},"author":225,"featured_media":38575,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2033],"tags":[2432,2425,2426,2431,2433,2428,2427,2429,2435,2434,2430],"class_list":["post-38574","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-immunology","tag-crs-assays","tag-cytokine-multiplexing","tag-cytokine-quantification","tag-cytokine-release-syndrome","tag-immunoassays","tag-luminex","tag-microvolume-assays","tag-olink","tag-plasma-cytokines","tag-sample-validation","tag-simoa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays | Immunostep Biotech<\/title>\n<meta name=\"description\" content=\"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.- Cytokine multiplexing-\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays | Immunostep Biotech\" \/>\n<meta property=\"og:description\" content=\"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.- Cytokine multiplexing-\" \/>\n<meta property=\"og:url\" content=\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/\" \/>\n<meta property=\"og:site_name\" content=\"Immunostep Biotech\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/immunostepsl\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-14T08:19:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-22T13:45:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"850\" \/>\n\t<meta property=\"og:image:height\" content=\"478\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"\u00c1ngela Cabestrero\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Immunostep\" \/>\n<meta name=\"twitter:site\" content=\"@Immunostep\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c1ngela Cabestrero\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/\"},\"author\":{\"name\":\"\u00c1ngela Cabestrero\",\"@id\":\"https:\/\/immunostep.com\/#\/schema\/person\/6f7086a7900eb41588a2465bcae5f427\"},\"headline\":\"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays\",\"datePublished\":\"2026-01-14T08:19:05+00:00\",\"dateModified\":\"2025-12-22T13:45:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/\"},\"wordCount\":533,\"publisher\":{\"@id\":\"https:\/\/immunostep.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp\",\"keywords\":[\"CRS assays\",\"cytokine multiplexing\",\"cytokine quantification\",\"cytokine release syndrome\",\"immunoassays\",\"Luminex\",\"microvolume assays\",\"Olink\",\"plasma cytokines\",\"sample validation\",\"Simoa\"],\"articleSection\":[\"Immunology\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/\",\"url\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/\",\"name\":\"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays | Immunostep Biotech\",\"isPartOf\":{\"@id\":\"https:\/\/immunostep.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp\",\"datePublished\":\"2026-01-14T08:19:05+00:00\",\"dateModified\":\"2025-12-22T13:45:35+00:00\",\"description\":\"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.- Cytokine multiplexing-\",\"breadcrumb\":{\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#primaryimage\",\"url\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp\",\"contentUrl\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp\",\"width\":850,\"height\":478,\"caption\":\"cytokine multiplexing microvolumes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/immunostep.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/immunostep.com\/#website\",\"url\":\"https:\/\/immunostep.com\/\",\"name\":\"Immunostep Biotech\",\"description\":\"Innovating to deliver high-performance technology for Research and Diagnosis\",\"publisher\":{\"@id\":\"https:\/\/immunostep.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/immunostep.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/immunostep.com\/#organization\",\"name\":\"Immunostep Biotech\",\"url\":\"https:\/\/immunostep.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/immunostep.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2021\/10\/logo-web-color.png\",\"contentUrl\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2021\/10\/logo-web-color.png\",\"width\":1299,\"height\":591,\"caption\":\"Immunostep Biotech\"},\"image\":{\"@id\":\"https:\/\/immunostep.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/immunostepsl\/\",\"https:\/\/x.com\/Immunostep\",\"https:\/\/www.linkedin.com\/company\/immunostepsl\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/immunostep.com\/#\/schema\/person\/6f7086a7900eb41588a2465bcae5f427\",\"name\":\"\u00c1ngela Cabestrero\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/immunostep.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/378033e78b9b0300f6f50aeac830c5cf?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/378033e78b9b0300f6f50aeac830c5cf?s=96&d=mm&r=g\",\"caption\":\"\u00c1ngela Cabestrero\"},\"url\":\"https:\/\/immunostep.com\/es\/author\/acabestrero\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays | Immunostep Biotech","description":"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.- Cytokine multiplexing-","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/","og_locale":"es_ES","og_type":"article","og_title":"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays | Immunostep Biotech","og_description":"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.- Cytokine multiplexing-","og_url":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/","og_site_name":"Immunostep Biotech","article_publisher":"https:\/\/www.facebook.com\/immunostepsl\/","article_published_time":"2026-01-14T08:19:05+00:00","article_modified_time":"2025-12-22T13:45:35+00:00","og_image":[{"width":850,"height":478,"url":"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp","type":"image\/webp"}],"author":"\u00c1ngela Cabestrero","twitter_card":"summary_large_image","twitter_creator":"@Immunostep","twitter_site":"@Immunostep","twitter_misc":{"Escrito por":"\u00c1ngela Cabestrero","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#article","isPartOf":{"@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/"},"author":{"name":"\u00c1ngela Cabestrero","@id":"https:\/\/immunostep.com\/#\/schema\/person\/6f7086a7900eb41588a2465bcae5f427"},"headline":"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays","datePublished":"2026-01-14T08:19:05+00:00","dateModified":"2025-12-22T13:45:35+00:00","mainEntityOfPage":{"@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/"},"wordCount":533,"publisher":{"@id":"https:\/\/immunostep.com\/#organization"},"image":{"@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#primaryimage"},"thumbnailUrl":"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp","keywords":["CRS assays","cytokine multiplexing","cytokine quantification","cytokine release syndrome","immunoassays","Luminex","microvolume assays","Olink","plasma cytokines","sample validation","Simoa"],"articleSection":["Immunology"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/","url":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/","name":"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays | Immunostep Biotech","isPartOf":{"@id":"https:\/\/immunostep.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#primaryimage"},"image":{"@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#primaryimage"},"thumbnailUrl":"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp","datePublished":"2026-01-14T08:19:05+00:00","dateModified":"2025-12-22T13:45:35+00:00","description":"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.- Cytokine multiplexing-","breadcrumb":{"@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#primaryimage","url":"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp","contentUrl":"https:\/\/immunostep.com\/wp-content\/uploads\/2025\/12\/cytokine-multiplexing-microvolumes.webp","width":850,"height":478,"caption":"cytokine multiplexing microvolumes"},{"@type":"BreadcrumbList","@id":"https:\/\/immunostep.com\/2026\/01\/14\/advanced-multiplexing-for-cytokine-quantification-in-microvolumes-technical-challenges-and-validation-in-crs-assays\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/immunostep.com\/es\/"},{"@type":"ListItem","position":2,"name":"Advanced Multiplexing for Cytokine Quantification in Microvolumes: Technical Challenges and Validation in CRS Assays"}]},{"@type":"WebSite","@id":"https:\/\/immunostep.com\/#website","url":"https:\/\/immunostep.com\/","name":"Immunostep Biotech","description":"Innovating to deliver high-performance technology for Research and Diagnosis","publisher":{"@id":"https:\/\/immunostep.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/immunostep.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/immunostep.com\/#organization","name":"Immunostep Biotech","url":"https:\/\/immunostep.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/immunostep.com\/#\/schema\/logo\/image\/","url":"https:\/\/immunostep.com\/wp-content\/uploads\/2021\/10\/logo-web-color.png","contentUrl":"https:\/\/immunostep.com\/wp-content\/uploads\/2021\/10\/logo-web-color.png","width":1299,"height":591,"caption":"Immunostep Biotech"},"image":{"@id":"https:\/\/immunostep.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/immunostepsl\/","https:\/\/x.com\/Immunostep","https:\/\/www.linkedin.com\/company\/immunostepsl\/"]},{"@type":"Person","@id":"https:\/\/immunostep.com\/#\/schema\/person\/6f7086a7900eb41588a2465bcae5f427","name":"\u00c1ngela Cabestrero","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/immunostep.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/378033e78b9b0300f6f50aeac830c5cf?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/378033e78b9b0300f6f50aeac830c5cf?s=96&d=mm&r=g","caption":"\u00c1ngela Cabestrero"},"url":"https:\/\/immunostep.com\/es\/author\/acabestrero\/"}]}},"_links":{"self":[{"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/posts\/38574"}],"collection":[{"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/users\/225"}],"replies":[{"embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/comments?post=38574"}],"version-history":[{"count":1,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/posts\/38574\/revisions"}],"predecessor-version":[{"id":38577,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/posts\/38574\/revisions\/38577"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/media\/38575"}],"wp:attachment":[{"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/media?parent=38574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/categories?post=38574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/tags?post=38574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}